NovaBay Pharmaceuticals (NBY)
(Delayed Data from AMEX)
$1.36 USD
-0.17 (-11.11%)
Updated Oct 3, 2025 04:00 PM ET
After-Market: $1.38 +0.02 (1.47%) 7:58 PM ET
3-Hold of 5 3
F Value B Growth C Momentum D VGM
Fundamental Charts
About Dividend Yield (TTM)
NovaBay Pharmaceuticals, Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical - Drugs industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
NBY 1.36 -0.17(-11.11%)
Will NBY be a Portfolio Killer in October?
Zacks Investment Research is releasing its prediction for NBY based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for NBY
Brookdale Senior Living (BKD) Reports Q1 Loss, Lags Revenue Estimates
NovaBay Pharmaceuticals (NBY) Upgraded to Buy: Here's Why
NBY: What are Zacks experts saying now?
Zacks Private Portfolio Services
Verve Therapeutics (VERV) Reports Q3 Loss, Tops Revenue Estimates
Other News for NBY
NBY forms 20 Day Moving Average Resistance on October 3
NovaBay (NBY) Files for $200 Million Mixed Securities Shelf
NBY Crossed Above 20 Day Moving Average on October 2
NovaBay files $200M mixed securities shelf
NovaBay files $200M mixed securities shelf